>
pdufa.bio

Z-Endoxifen

Updated ยทnext FDA decision on the calendar

Z-Endoxifen is a Atossa Therapeutics, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

ATOS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Atossa Therapeutics, Inc. (ATOS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2026ATOS

Questions

When is Z-Endoxifen's next FDA decision or readout?

The next tracked catalyst for Z-Endoxifen is a Readout in Nov 2026.

What happened at Z-Endoxifen's most recent FDA decision?

No FDA decision for Z-Endoxifen is in our archive yet.

Who makes Z-Endoxifen?

Atossa Therapeutics, Inc. (ATOS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.